Target
Uracil-DNA glycosylase
Ligand
BDBM294507
Substrate
n/a
Meas. Tech.
Processive DNA synthesis assay
pH
7.5±n/a
EC50
19900±n/a nM
Comments
extracted
Citation
 Ricciardi, RPReitz, ABParker, MHBaugh, SDNuth, MGuan, H Antivirals against molluscum contagiosum virus US Patent  US10112895 Publication Date 10/30/2018 
Target
Name:
Uracil-DNA glycosylase
Synonyms:
OPG116 | UDG | UNG | UNG_VACCW
Type:
PROTEIN
Mol. Mass.:
25071.48
Organism:
Vaccinia virus (strain Western Reserve) (VACV) (Vaccinia virus (strainWR))
Description:
ChEMBL_747132
Residue:
218
Sequence:
MNSVTVSHAPYTITYHDDWEPVMSQLVEFYNEVASWLLRDETSPIPDKFFIQLKQPLRNKRVCVCGIDPYPKDGTGVPFESPNFTKKSIKEIASSISRLTGVIDYKGYNLNIIDGVIPWNYYLSCKLGETKSHAIYWDKISKLLLQHITKHVSVLYCLGKTDYSNIRAKLESPVTTIVGYHPAARDRQFEKDRSFEIINVLLELDNKAPINWAQGFIY
  
Inhibitor
Name:
BDBM294507
Synonyms:
4-[[5-bromo-2-[(4- fluorophenyl)methoxy]phenyl] methylamino]phenol | US10112895, Compound 1
Type:
Small organic molecule
Emp. Form.:
C20H17BrFNO2
Mol. Mass.:
402.257
SMILES:
Oc1ccc(NCc2cc(Br)ccc2OCc2ccc(F)cc2)cc1
Structure:
Search PDB for entries with ligand similarity: